Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Cell Therapy Human Raw Materials Market Growth Potential: How Will Market Size Shift Through 2030?
The market for cell therapy human raw materials has experienced significant expansion recently. This market is projected to increase from $3.36 billion in 2025 to $4.03 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 19.8%. Historically, this expansion was driven by the early adoption of stem cell therapies, the broadening of academic research in cell therapy, a rise in clinical trials for cell-based treatments, enhanced access to human-derived biological materials, and increased funding for regenerative medicine research.
The cell therapy human raw materials market size is anticipated to undergo significant expansion in the coming years. It is projected to achieve a valuation of $7.71 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 17.6%. This growth during the forecast period can be attributed to an increase in approved cell therapy products, growing demand for allogeneic and autologous therapies, intensified regulatory oversight on raw material quality, the expansion of commercial-scale cell therapy manufacturing, and the growth of oncology-focused cell therapies. Prominent trends for the forecast period include a rising demand for xeno-free and human-derived raw materials, a greater emphasis on GMP-grade and clinical-grade inputs, increasing standardization of human cell sourcing and processing, an expansion of raw material requirements for advanced cell therapies, and the establishment of long-term supply agreements for critical human raw materials.
Get A Free Sample Report With In-Depth Market Insights:
Cell Therapy Human Raw Materials Market Growth Catalysts And Demand Drivers
The increasing acceptance of regenerative medicine is anticipated to propel the cell therapy human raw materials market into the future. Regenerative medicine encompasses therapeutic strategies designed to repair, replace, or renew impaired tissues and organs, employing techniques such as stem cells, gene therapy, tissue engineering, or other biological methods to restore proper function. Its adoption is expanding because of breakthroughs in biotechnology, a deeper comprehension of cellular processes, the rising need for personalized treatment, and its capability to meet currently unaddressed medical requirements. The cell therapy human raw materials market plays a crucial role in regenerative medicine by providing vital biological components necessary for the creation of standardized, efficacious, and dependable cell-based treatments. For example, data from August 2023, reported by the Alliance for Regenerative Medicine, a US-based non-profit entity, showed a global count of 2,760 cell, gene, and tissue-engineering therapeutic developers in Q1 2023, representing a 101% increase from the 1,369 developers recorded in Q1 2022. Consequently, the growing integration of regenerative medicine is propelling the cell therapy human raw materials market.
Cell Therapy Human Raw Materials Market Segment Landscape: Which Areas Lead Development?
The cell therapy human raw materials market covered in this report is segmented –
1) By Product: Cell Culture Media, Cell Culture Sera, Cell Culture Supplements, Reagents And Buffers, Other Raw Materials
2) By Type Of Cell Therapy: Dendritic Cell Therapy, Natural Killer (NK) Cell Therapy, Stem Cell Therapy, T-Cell Therapy
3) By End-Use: Biopharmaceutical And Pharmaceutical Companies, Contract Research Organizations (CROs) And Contract Manufacturing Organization (CMOs), Academic And Research Institutions
Subsegments:
1) By Cell Culture Media: Serum-Free Media, Serum-Based Media, Defined Media, Specialized Media (E.G., For Stem Cells)
2) By Cell Culture Sera: Human Serum
3) By Cell Culture Supplements: Growth Factors, Cytokines, Peptides
4) By Reagents And Buffers: Enzymes (E.G., Trypsin), Ph Buffers, Cryoprotectants
5) By Other Raw Materials: Cell-Free DNA, Plasma And Platelet-Rich Plasma (PRP)
Cell Therapy Human Raw Materials Market Trends Shaping Long-Term Demand
Leading firms within the cell therapy human raw materials market are progressively concentrating on creating chemically defined cell culture mediums to expedite the advancement of cell therapies. Such a medium serves as a nutrient-dense solution, specifically formulated to supply the crucial nutrients, growth factors, and environmental conditions required for the in vitro growth and proliferation of cells outside their natural habitat. An example of this trend occurred in May 2023 when Lonza Group AG, a healthcare manufacturing entity based in Switzerland, introduced its TheraPEAK T-VIVO Cell Culture Medium. This new product boasts a chemically defined, serum-free, and animal component-free composition, incorporates recombinant proteins, offers superior support for cell culture and expansion, and provides application aid, thereby guaranteeing uniformity, security, and adherence to regulations in the production of cell therapies. The medium signifies considerable technological progress through its lack of animal components, precise chemical definition, and advantageous regulatory properties, all of which contribute to heightened safety, quality, and regulatory conformity.
Cell Therapy Human Raw Materials Market Industry Leaders And Competitive Landscape
Major companies operating in the cell therapy human raw materials market are Thermo Fisher Scientific Inc., Merck KGaA, Lonza Group Ltd., Sartorius AG, Miltenyi Biotec, Bio-Techne Corporation, STEMCELL Technologies, PromoCell GmbH, AllCells LLC, BioIVT LLC, ACROBiosystems, Sartorius CellGenix GmbH, RoosterBio Inc., Takara Bio Inc., Grifols S.A., Charles River Laboratories, WuXi AppTec, Catalent Inc., Fujifilm Cellular Dynamics Inc., Orgenesis Inc.
View The Full Cell Therapy Human Raw Materials Market Report:
Cell Therapy Human Raw Materials Market Geographic Landscape: Which Region Leads Industry Growth?
North America was the largest region in the cell therapy human raw materials market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell therapy human raw materials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model